No abstract

No abstract

Introduction Parkinson's disease is one of the progressive neurodegenerative diseases from which people suffer for years. The mechanism of this disease is associated with a decrease in the number of dopaminergic neurons in the substantia nigra (SN) while Lewy bodies are still present. As a result, both motor—ridity, tremor, and bradykinesia—and non‐motor symptoms such as anxiety and depression. Nowadays, it is well known that the cause behind Parkinson's disease is mainly environmental changes, genetic susceptibility, and toxins. Unfortunately, there is no cure for the disease but treatments. The replacement of lost neurons, α‐synuclein and apomorphine, is currently being studied for new therapies. This article focuses on history, mechanism, factors causing Parkinson's disease as well as future therapies for the cure of the diseases. Methodology Data were collected from medical journals published on PubMed, The Lancet, Cells, and Nature Reviews Neurology databases with a predefined search strategy. All articles considering new therapies for Parkinson's disease were considered. Results The pathophysiology of Parkinson's disease is currently reasonably understood. However, there is no definitive cure so all the treatments focus mainly on reducing or limiting the symptoms. Current treatment studies focus on genetics, replacing lost neurons, α‐synuclein and apomorphine. Conclusion Parkinson's disease is the most common movement disorder worldwide because of the loss of dopaminergic neurons in the substantia nigra. Its symptoms include motor dysfunctions such as rigidity, tremor, and bradykinesia and non‐motor dysfunctions such as anxiety and depression. Through genetics, environmental changes and toxins analysis, it is now known that future new therapies are working on replacing lost neurons, α‐synuclein and apomorphine.

Highlights COVID-19 pandemic has affected medical education and practice due to the closure of schools globally. Most medical schools and educators are concerned about the safety of cadavers for dissection during the COVID-19 pandemic. There is currently no proof of people being infected due to exposure to COVID-19 dead bodies. Common fixatives are viable against COVID-19 depending on time and temperature. Standard operating procedures must be followed when handling dead bodies during and after the COVID-19 pandemic. COVID-19 pandemic could be a pointer for the full incorporation of technology in the Anatomy and medical curriculum.